DGAP-News: UMS AG on Track in First Half of 2014


 
DGAP-News: UMS United Medical Systems International AG / Key word(s): Half Year Results/Quarter Results UMS AG on Track in First Half of 2014 14.08.2014 / 09:48 --------------------------------------------------------------------- UMS AG on Track in First Half of 2014 - Exchange-rate-adjusted revenues and earnings stable - Forecast confirmed - Dividend policy unchanged Hamburg, August 14, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) has published its figures for the first half of 2014. After an initially subdued start, business has revived, with revenues and earnings at the previous year's level when adjusted for the negative effects of the weak U.S. dollar. As a result, UMS is confirming its full-year forecast for 2014: Assuming stable exchange rates, the Company projects earnings per share of 50 to 55 cents (2013: 52 cents) with consolidated sales of EUR39 to 42 million (2013: EUR39.8 million). That being the case, UMS intends to maintain its shareholder-friendly dividend policy. Consolidated sales under IFRS were EUR19.4 million in the first half of 2014, following EUR20.1 million in the same period last year. This slight decline was exclusively attributable to the effects of the U.S. dollar, which was significantly weaker than in the prior-year period. At EUR4.9 million, net income was down somewhat from the previous year (EUR5.0 million), also solely due to exchange rate effects. UMS's earnings per share (EPS) came to 24 cents in the first half of 2014 following 24 cents in the same period last year. "In the second quarter of 2014, we made additional progress on several major projects that are already benefiting us and will continue to benefit us in the second half," said Jorgen Madsen, CEO of UMS AG. "Therefore, we are optimistic about the second half of the year and are confirming our forecast for the full fiscal year. Our shareholders can expect another large dividend for fiscal 2014." The complete report for the first half of 2014 is available in German and English on UMS AG's website at www.umsag.com. About UMS AG UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of high-class medical systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has some 220 employees worldwide and serves over 650 customers. Contact Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-mail: [email protected] --------------------------------------------------------------------- 14.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Germany Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: [email protected] Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 282276 14.08.2014


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu UMS United Medical Systems International AG  ISIN: DE0005493654 können Sie bei EQS abrufen


in Auflösung , 549365